A McGill-led study is challenging a popular theory about how dopamine drives movement, a discovery that could shift how ...
Results showed CNS target engagement with reduction in GCase substrate glucosylsphingosine (GluSph) in cerebrospinal fluid ...
A McGill-led study is challenging a popular theory about how dopamine drives movement, a discovery that could shift how ...
News-Medical.Net on MSN
Rethinking dopamine’s role in movement and Parkinson’s disease
A McGill-led study is challenging a popular theory about how dopamine drives movement, a discovery that could shift how ...
Scientists have discovered that gut-born bacteria may hold the secret for treatments of everything from IBD to Parkinson’s ...
The treatment uses a modified, harmless virus to deliver healthy genes to a patient’s cells to treat genetic diseases. Read ...
People with restless leg syndrome may also have a higher risk for Parkinson's disease, a study from the Republic of Korea has ...
Parkinson's disease (PD) is an age-related, progressive, neurodegenerative condition, caused by loss of dopamine-producing ...
The event brings together leading experts, patients and care partners for a day of education on navigating the disease.
From a fresh water production breakthrough to a promising Parkinson's treatment, here are some highlights from SCMP's recent ...
Abbvie ($ABBV) announced an update on their ongoing clinical study. AbbVie has announced a new clinical study titled ‘A ...
Swiss biotech AC Immune has said that its vaccine-like alpha-synuclein-targeted immunotherapy has shown promise in slowing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback